Letter: Raynaud's phenomenon as side effect of beta-blockers.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001262:Atenolol / Q000009:adverse effects; D006801:Humans; D010096:Oxprenolol / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D011928:Raynaud Disease / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D010096:Oxprenolol; D011433:Propranolol